Expanded Access for Treatment With Imetelstat

NCT05937568 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndromes

Interventions

DRUG: Imetelstat

Sponsor

Geron Corporation